Lexeo Therapeutics, Inc.LXEO
Price (close)
$3.39
Market cap
$278.1M
P/E
—
Revenue (TTM)
—
Net income
-$87.3M
Dividend yield
—
1-year total return
-47.8%
Net margin
—
Revenue growth
—
Debt / equity
—
What Lexeo Therapeutics, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $654,000 | — | — | — |
| Net income | — | -$59.3M | -$66.4M | -$98.3M | -$100.0M |
| Free cash flow | — | -$55.2M | -$59.6M | -$81.6M | -$99.0M |
More on LXEO.
- Lexeo Therapeutics, Inc. summary
- Lexeo Therapeutics, Inc. financial statements
- Lexeo Therapeutics, Inc. key metrics
- Lexeo Therapeutics, Inc. health scores and style box
- Lexeo Therapeutics, Inc. earnings
- Lexeo Therapeutics, Inc. dividends
- Lexeo Therapeutics, Inc. valuation
- Lexeo Therapeutics, Inc. ownership and insiders
- Lexeo Therapeutics, Inc. peers
Figures from Lexeo Therapeutics, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.